Fig. 3From: Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictionsPlot of the model predicted against experimental anti-hepatitis C bioactivity valuesBack to article page